Journal of the National Medical Association 1989-10-01

Swainsonine: a new antineoplastic immunomodulator.

S Mohla, M J Humphries, S L White, K Matsumoto, S A Newton, C C Sampson, D Bowen, K Olden

Index: J. Natl. Med. Assoc. 81(10) , 1049-56, (1989)

Full Text: HTML

Abstract

Swainsonine, an indolizidine alkaloid with immunomodulatory activity, has been found to be effective in inhibiting metastatic dissemination and growth of primary tumors of both murine and human origins. The unique ability of swainsonine to exhibit antimetastatic, anti-proliferative, and immunomodulatory activity imparts this drug a promising future in cancer therapy.


Related Compounds

Related Articles:

Production, HPLC analysis, and in situ apoptotic activities of swainsonine toward lepidopteran, Sf-21 cell line.

2014-01-01

[Biotechnol. Prog. 30(5) , 1196-205, (2014)]

DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.

2011-01-01

[Nucleic Acids Res. 39 , D1035-41., (2011)]

Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.

2012-12-01

[Oncol. Rep. 28(6) , 2091-100, (2012)]

Swainsonine as a lysosomal toxin affects dopaminergic neurons.

2012-12-01

[J. Neural Transm. Gen. Sect. 119(12) , 1483-90, (2012)]

Identification of a new locoweed (Oxytropis serioopetala) and its clinical and pathological features in poisoned rabbits.

2012-08-01

[J. Vet. Med. Sci. 74(8) , 989-93, (2012)]

More Articles...